ARTICLE | Clinical News
Spherix preclinical data
August 20, 2012 7:00 AM UTC
In mice prone to hyperlipidemia, SPX-106T for 4 weeks significantly reduced the growth rate of abdominal aortic aneurysms vs. untreated controls (p<0.05). Spherix said abdominal aortic aneurysms can b...